NEWS
Empowered Patient Podcast: Developing Potent Oral Kinase Inhibitor to Treat Recurrent Difficult to Treat Brain Cancer with Scott Megaffin Adastra Pharmaceuticals

Scott Megaffin, CEO, Adastra Pharmaceuticals has taken on the challenge of developing first-in-class innovative therapeutics for the treatment of cancers with high unmet needs such as high-grade gliomas.  He talks about the Phase 1b clinical trial conducted by the National Cancer Institute evaluating zotiraciclib, a potent oral cyclin-dependent kinase 9 inhibitor in combination with temozolomide […]

Different Types of COVID-19 Vaccines With Dr Seth Lederman

Across the globe, we are seeing the rollout of a number of different vaccines that are designed to protect against COVID-19. In this installment of Teach Me in 10, we’re joined by Dr Seth Lederman, a physician, scientist and the CEO of Tonix Pharmaceuticals. Dr Lederman talks us through the main types of COVID-19 vaccines […]

Valisure links ‘unstable’ Zantac and its ilk to carcinogen build-up, cancer risk

When online pharmacy Valisure discovered high levels of a likely carcinogen in Zantac and its generic copycats in 2019, global recalls ensued. Contamination was one fear, but the bigger issue, as Valisure saw it, was the instability of the ranitidine molecule itself. Now, the company has rolled out data supporting its suspicions that the once-popular heartburn […]